HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J C G Halford Selected Research

Overweight

1/2006Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J C G Halford Research Topics

Disease

8Weight Gain
07/2010 - 02/2005
5Weight Loss (Weight Reduction)
01/2017 - 03/2004
4Obesity
01/2023 - 01/2006
4Hyperphagia (Overeating)
07/2010 - 08/2005
3Anorexia
02/2005 - 10/2003
2Type 2 Diabetes Mellitus (MODY)
05/2007 - 09/2006
1COVID-19
06/2021
1Food Addiction
11/2017
1Bulimia (Binge Eating)
11/2017
1Autonomic Nervous System Diseases (Dysautonomia)
06/2013
1Narcolepsy
06/2013
1Cataplexy
06/2013
1Chronic Disease (Chronic Diseases)
01/2006
1Necrosis
01/2006
1Substance-Related Disorders (Drug Abuse)
01/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2006
1Overweight
01/2006
1Drug-Related Side Effects and Adverse Reactions
09/2005
1Insulin Resistance
08/2005
1Nausea
05/2005
1Body Weight (Weight, Body)
07/2003
1Tachycardia (Tachyarrhythmias)
10/2002
1Hypertension (High Blood Pressure)
10/2002

Drug/Important Bio-Agent (IBA)

5Antipsychotic Agents (Antipsychotics)IBA
07/2010 - 07/2003
4Olanzapine (Zyprexa)FDA Link
07/2010 - 08/2005
3GhrelinIBA
06/2013 - 05/2007
3Insulin (Novolin)FDA Link
02/2008 - 08/2005
3Appetite Depressants (Anorectics)IBA
05/2005 - 10/2003
31- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA
05/2005 - 03/2004
2OrexinsIBA
06/2013 - 10/2002
2ProlactinIBA
02/2008 - 08/2005
2Glucose (Dextrose)FDA LinkGeneric
02/2008 - 08/2005
2AdiponectinIBA
06/2007 - 08/2005
1Sweetening Agents (Sweeteners)IBA
01/2023
1SteamIBA
06/2021
1BESIBA
11/2017
1Non-Nutritive SweetenersIBA
01/2017
1Clozapine (Clozaril)FDA LinkGeneric
02/2008
1LeptinIBA
02/2008
1Metformin (Glucophage)FDA LinkGeneric
05/2007
1Peptide YYIBA
09/2006
1Indomethacin (Indometacin)FDA LinkGeneric
01/2006
1RimonabantIBA
01/2006
1LipidsIBA
01/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1CytokinesIBA
01/2006
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2006
1EndocannabinoidsIBA
01/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2005
1NeuropeptidesIBA
09/2005
1Quinine (Quinson)FDA Link
10/2003
1Risperidone (Risperdal Consta)FDA LinkGeneric
07/2003
1Opioid Analgesics (Opioids)IBA
10/2002

Therapy/Procedure

1Therapeutics
05/2007
1Analgesia
10/2002